✦ LIBER ✦

Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors

✍ Scribed by C. Massard, R. Salazar, J. P. Armand, M. Majem, E. Deutsch, M. García, A. Oaknin, E. M. Fernández-García, A. Soto, J. C. Soria

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Spisulosine (ES-285) given as a weekly t

✍ P. Schöffski; H. Dumez; R. Ruijter; B. Miguel-Lillo; A. Soto-Matos; V. Alfaro; G 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 285 KB

A phase 1 study of OSI-211 given as an i

✍ K. Gelmon; H. Hirte; B. Fisher; W. Walsh; M. Ptaszynski; M. Hamilton; N. Onetto; 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 283 KB

A phase I and pharmacokinetic study of D

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

27 ORAL Phase I dose escalation study of

✍ M. De Jonge; N. Steeghs; J. Verweij; J.W.R. Nortier; F. Eskens; J. Ouwerkerk; C. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Phase I dose-escalation study of vinflun

✍ Calvo, E.; Vermorken, J. B.; Hiret, S.; Rodon, J.; Cortes, J.; Senellart, H.; de 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 242 KB

343 POSTER Phase I dose escalation study

✍ H.A. Burris; G. Hudes; S. Jones; J. Cheng; D. Spigel; M. Mariani; H. Macdonald; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB